ABVX

NASD Abivax SA Sponsored ADR
Sep 29, 2026 · 9:15 AM ET LAST TRADE Market Closed

$97.00 ↑ +0.15 (+0.15%) Trading Up from the previous close of $96.85

YTD change
-28.07%
vs 20-day SMA
-9.83%
vs 200-day SMA
-18.09%

Price ranges

Previous day
$91.45 $97.27
open $91.50 close $96.85
+$5.35 (+5.85%)
Today
$0.00 $0.00
$97.00
Past week
$90.96 $103.45
from $103.45 now $97.00
-$6.45 (-6.23%)
Past month
$90.96 $120.63
from $113.35 now $97.00
-$16.35 (-14.42%)
This year
$69.81 $147.98
from $134.86 now $97.00
-$37.86 (-28.07%)

Price & Performance

-4.65 (-4.58%) / 6M

$66.73$94.63$122.52$150.42Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 34.8% away from all-time highs of $148.83
  • ABVX is down 28% since the beginning of the year
  • ABVX is up 16% over the past 12 months
  • ABVX is down 14% over the past 1 month
  • 9% of all ABVX investors are betting against ABVX

ABVX reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +16.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.68205
Earnings momentum -69.5% Quarterly EPS growth
Quarterly change -69.5%

Valuation

P/E ratio N/A
Enterprise value $7.3B
Beta 1.03

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$460.0M
Debt$1.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $8.4B

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.00 +2.66%
ARGX argenx SE Sponsored ADR $972.25 +1.33%
ONC BeOne Medicines Ltd. Sponsored ADR $367.00 +1.70%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.66 +0.07%
INCY Incyte Corporation $124.82 +0.75%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.